Importer of Controlled Substances Application: Agilent Technologies, 32422-32423 [2020-11546]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES 32422 Federal Register / Vol. 85, No. 104 / Friday, May 29, 2020 / Notices provide a report containing its advice as to the probable economic effect of providing duty-free treatment for imports of currently dutiable products from Kenya on (i) industries in the United States producing like or directly competitive products, and (ii) consumers. The USTR asked that the Commission’s analysis consider each article in chapters 1 through 97 of the Harmonized Tariff Schedule of the United States (HTS) for which U.S. tariffs will remain, taking into account implementation of U.S. commitments in the World Trade Organization. The USTR asked that the advice be based on the HTS in effect during 2020 and trade data for 2019. In addition, the USTR requested that the Commission prepare an assessment, as described in section 105(a)(2)(B)(i)(III) of the Bipartisan Congressional Trade Priorities and Accountability Act of 2015, of the probable economic effects of eliminating tariffs on imports from Kenya of those agricultural products described in the list attached to the USTR’s request letter on (i) industries in the United States producing the products concerned, and (ii) the U.S. economy as a whole. The USTR’s request letter and list of agricultural products are posted on the Commission’s website at https:// www.usitc.gov. The Commission will provide its report to the USTR by September 16, 2020, or as soon as possible. The USTR indicated that those sections of the Commission’s report that relate to the advice and assessment of probable economic effects will be classified. The USTR also indicated that he considers the Commission’s report to be an interagency memorandum that will contain pre-decisional advice and be subject to the deliberative process privilege. Public Hearing: A public hearing in connection with this investigation will be held beginning at 9:30 a.m. on July 7, 2020, using Go To Meeting. Information about the hearing, will be posted on the Commission’s website at (https://usitc.gov/research_and_ analysis/what_we_are_working_ on.htm). Once on that web page, scroll down to the entry for Investigation No. 131–046, U.S.-Kenya Trade Agreement: Advice on the Probable Economic Effect of Providing Duty-free Treatment for Currently Dutiable Imports, and click on the link to ‘‘hearing instructions.’’ Requests to appear at the public hearing should be filed with the Secretary no later than 5:15 p.m., June 10, 2020, in accordance with the requirements in the ‘‘Written Submissions’’ section below. All prehearing briefs and statements VerDate Sep<11>2014 17:06 May 28, 2020 Jkt 250001 should be filed not later than 5:15 p.m., June 12, 2020, and all post-hearing briefs and statements should be filed not later than 5:15 p.m., July 14, 2020. All requests to appear, and pre- and posthearing briefs and statements should be filed in accordance with the requirements of the ‘‘written submissions’’ section below. Written Submissions: In lieu of or in addition to participating in the hearing, interested parties are invited to file written submissions concerning this investigation. All written submissions should be addressed to the Secretary, and should be received not later than 5:15 p.m., July 14, 2020. All written submissions must conform to the provisions of section 201.8 of the Commission’s Rules of Practice and Procedure (19 CFR 201.8), as temporarily amended by 85 FR 15798 (March 19, 2020). Under that rule waiver, the Office of the Secretary will accept only electronic filings at this time. Filings must be made through the Commission’s Electronic Document Information System (EDIS, https:// edis.usitc.gov). No in-person paperbased filings or paper copies of any electronic filings will be accepted until further notice. Persons with questions regarding electronic filing should contact the Office of the Secretary, Docket Services Division (202–205– 1802) or consult the Commission’s Handbook on Filing Procedures. Confidential Business Information: Any submissions that contain confidential business information must also conform to the requirements of section 201.6 of the Commission’s Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the rules requires that the cover of the document and the individual pages be clearly marked as to whether they are the ‘‘confidential’’ or ‘‘nonconfidential’’ version, and that the confidential business information is clearly identified by means of brackets. All written submissions, except for confidential business information, will be made available for inspection by interested parties. The Commission may include some or all of the confidential business information submitted in the course of this investigation in the report it sends to the USTR. Additionally, all information, including confidential business information, submitted in this investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel (a) for cybersecurity purposes or (b) in monitoring user activity on U.S. government classified networks. The Commission will not otherwise disclose any confidential business information in a way that would reveal the operations of the firm supplying the information. Summaries of Written Submissions: Persons wishing to have a summary of their position included in the report should include a summary with their written submission and should mark the summary as having been provided for that purpose. The summary should be clearly marked as ‘‘summary for inclusion in the report’’ at the top of the page. The summary may not exceed 500 words, should be in MS Word format or a format that can be easily converted to MS Word, and should not include any confidential business information. The summary will be published as provided if it meets these requirements and is germane to the subject matter of the investigation. The Commission will list the name of the organization furnishing the summary and will include a link to the Commission’s Electronic Document Information System (EDIS) where the full written submission can be found. By order of the Commission. Issued: May 26, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–11600 Filed 5–28–20; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–651] Importer of Controlled Substances Application: Agilent Technologies ACTION: Notice of application. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 29, 2020. Such persons may also file a written request for a hearing on the application on or before June 29, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must DATES: E:\FR\FM\29MYN1.SGM 29MYN1 Federal Register / Vol. 85, No. 104 / Friday, May 29, 2020 / Notices reissuance to notify the public of the expanded functionality of this system, which now includes records of the adjudications of Attorney Discipline proceedings. This system will also adopt new and modified routine uses to better reflect the operational use of the system. DATES: In accordance with 5 U.S.C. 552a(e)(4) and (11), this notice is effective upon publication, subject to a 30-day period in which to comment on the routine uses, described below. Please submit any comments by June 29, 2020. ADDRESSES: The public, OMB, and Congress are invited to submit any comments to the United States Department of Justice, Office of Privacy and Civil Liberties, ATTN: Privacy Analyst, 145 N Street NE, Suite 8W.300, Washington, DC 20530, or by facsimile at 202–307–0693 or by email at Controlled privacy.compliance@usdoj.gov. To Drug code Schedule substance ensure proper handling, please reference the above CPCLO Order No. Marihuana ............. 7360 I on your correspondence. Tetrahydrocannabinols .................... 7370 I FOR FURTHER INFORMATION CONTACT: Michelle Curry, EOIR Senior Component Official for Privacy, EOIR The company plans to import the Office of the General Counsel, 5107 listed controlled substances in bulk Leesburg Pike Suite 2600, Falls Church, form for testing and calibration only. The listed controlled substances are not VA 22041, or by phone at 703–305– 0990, or by email at michelle.curry@ for human or animal use. No other usdoj.gov. activities for these drug codes are authorized for this registration. SUPPLEMENTARY INFORMATION: To protect the public, preserve the integrity of William T. McDermott, immigration proceedings and Assistant Administrator. adjudications, and maintain high [FR Doc. 2020–11546 Filed 5–28–20; 8:45 am] professional standards among BILLING CODE 4410–09–P immigration practitioners, EOIR implemented the regulation, ‘‘Professional Conduct for DEPARTMENT OF JUSTICE Practitioners—Rules and Procedures,’’ [CPCLO Order No. 004–2020] 65 FR 39513 (June 27, 2000). EOIR modified the rule in 2008 to increase the Privacy Act of 1974; Systems of number of grounds for discipline, Records improve the clarity and uniformity of the rules, and incorporate miscellaneous AGENCY: Executive Office for technical and procedural changes. See Immigration Review, United States ‘‘Professional Conduct for Department of Justice. Practitioners—Rules and Procedures, ACTION: Notice of a modified system of and Representation and Appearances,’’ records. 73 FR 76914 (Dec. 18, 2008). Effective SUMMARY: Pursuant to the Privacy Act of January 18, 2017, the rules were again 1974, and Office of Management and amended to extend discipline to Budget (OMB) Circular No. A–108, recognized organizations and to make notice is hereby given that the Executive minor modifications to the Office for Immigration Review reinstatement process. See ‘‘Recognition (hereinafter EOIR), a component within of Organizations and Accreditation of the United States Department of Justice Non-Attorney Representatives,’’ 81 FR (DOJ) or (Department), proposes to 92346 (Dec. 19, 2016). The term update and reissue a current DOJ ‘‘practitioners’’ applies to attorneys and System of Records, entitled EOIR–003 representatives who are authorized to Practitioner Complaint-Disciplinary represent aliens (but not attorneys Files. EOIR–003 will be renamed, representing the government) before ‘‘Attorney Discipline System.’’ The EOIR’s immigration court and the Board component proposes this update and of Immigration Appeals (BIA or Board), jbell on DSKJLSW7X2PROD with NOTICES be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 11, 2020, Agilent Technologies, 250 Smith Street, North Kingstown, Rhode Island 02852, applied to be registered as an importer of the following basic class(es) of controlled substances: VerDate Sep<11>2014 17:06 May 28, 2020 Jkt 250001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 32423 EOIR’s appellate component. The 2017 rule amendments have resulted in revisions to the Attorney Discipline System. The EOIR Attorney Discipline Program resides in the Office of the General Counsel (OGC). Proceedings created as a result of the Attorney Discipline Program may include paper and electronic files created by the Disciplinary Counsel, who is the program lead, attorneys supporting the program, or program staff, and paper and electronic adjudication files of the BIA, the Office of Chief Immigration Judge (OCIJ), and/or the Office of the Chief Administrative Hearing Officer (OCAHO). The new Attorney Discipline System expands the prior system by developing an electronic database that contains information to track complaints from receipt through final disposition. The system is segregated by need to know user controls and allows authorized users to track various stages of the proceedings. The system also contains templates to generate letters, notices, and decisions used in the attorney discipline process. The system can generate reports by case status and disposition. EOIR has applied routine uses to this system. Having these routine uses permits EOIR the necessary flexibility to disclose information in ways that are compatible with the purposes for which the information was collected. Specifically, EOIR has modified the language in the routine uses in paragraphs: 1–7; 9; 11 and 12 to conform their language to the current DOJ practice to describe the adopted uses. These modifications do not materially affect pre-existing routine uses as they are merely stylistic changes. EOIR has added a new routine use 10 to inform the public that the system and Attorney Discipline Program may be supported by contractors, grantees, experts, consultants, or students who will access the system on a need to know basis when necessary to accomplish an agency function related to this system of records. EOIR has also added new routine use 13, to address information release(s) in the event of a suspected or confirmed breach of the system, consistent with OMB guidance to federal agencies (OMB Memorandum 17–12, Preparing for and Responding to a Breach of Personally Identifiable Information (PII)). Finally, EOIR has added routine use 14 to allow release to third-party entities or individuals to the extent deemed necessary to elicit information from them or their cooperation to carry out authorized activities of EOIR. E:\FR\FM\29MYN1.SGM 29MYN1

Agencies

[Federal Register Volume 85, Number 104 (Friday, May 29, 2020)]
[Notices]
[Pages 32422-32423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11546]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-651]


Importer of Controlled Substances Application: Agilent 
Technologies

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before June 29, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before June 29, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must

[[Page 32423]]

be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152. All request for a 
hearing should also be sent to: (1) Drug Enforcement Administration, 
Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 
22152; and (2) Drug Enforcement Administration, Attn: DEA Federal 
Register Representative/DPW, 8701 Morrissette Drive, Springfield, 
Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on May 11, 2020, Agilent Technologies, 250 Smith Street, 
North Kingstown, Rhode Island 02852, applied to be registered as an 
importer of the following basic class(es) of controlled substances:

 
------------------------------------------------------------------------
              Controlled  substance                Drug code   Schedule
------------------------------------------------------------------------
Marihuana.......................................        7360           I
Tetrahydrocannabinols...........................        7370           I
------------------------------------------------------------------------

    The company plans to import the listed controlled substances in 
bulk form for testing and calibration only. The listed controlled 
substances are not for human or animal use. No other activities for 
these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-11546 Filed 5-28-20; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.